Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Larissa University Hospital |
---|---|
Information provided by: | Larissa University Hospital |
ClinicalTrials.gov Identifier: | NCT00600704 |
The investigators' hypothesis is that restriction of circulating fluids in comparison to a liberal fluid administration policy would lead to a reduction of allogenic red blood cells exposure in patients undergoing cardiopulmonary bypass (CPB) for primary coronary artery bypass graft supported by reinfusion of washed shed blood from thoracic cavities.
Condition | Intervention |
---|---|
Primary Coronary Artery Bypass Cardiac Surgery |
Procedure: Fluid Restriction Policy Procedure: Free fluid infusion |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Double Blind (Caregiver, Investigator), Active Control, Parallel Assignment |
Official Title: | Impact of Fluid Restriction Policy Added to Intra-Operative Cell Salvage in Reducing the Use of Red Cells in Cardiac Surgery |
Enrollment: | 130 |
Study Start Date: | November 2007 |
Estimated Study Completion Date: | November 2009 |
Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
GROUP A: Active Comparator
Infusion of Hes 130/0.4 up to 500 ml
|
Procedure: Fluid Restriction Policy
Infusion of Hes 130/0.4 up to 500 ml
|
GROUP B: Active Comparator
Free fluid infusion unless Hb< 6g/dl(allogenic blood use)
|
Procedure: Free fluid infusion
Free fluid infusion unless Hb< 6g/dl(allogenic blood use)
|
130 patients operated under equal conditions were assigned prospectively and randomly either for a restrictive protocol for intravenous fluid administration (group A, 65 pts) or not (group B, 65 pts). Transfusion guidelines were common for the two groups. The volumes of intravenous fluids, priming, "extra" volume on pump and cardioplegic solution and the volume of urine were recorded. Net erythrocyte volume loss was calculated.
The number of the transfused PRC was analyzed as a continuous variable. "Transfusion" was analyzed as a categorical characteristic. Analysis employed Student's two-tailed t-test, t-paired test and chitest.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Greece, THESALIA | |
Larissa University Hospital | |
LARISSA, THESALIA, Greece, 41110 |
Principal Investigator: | ATHINA KLEITSAKI, Dr | Larissa University Hospital |
Study Director: | GEORGE VRETZAKIS, M.D. PhD | Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece |
Study Chair: | KONSTANTINOS STAMOULIS, M.D. | Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece |
Study Chair: | CHRISTOS DRAGOUMANIS, M.D. PhD | Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece |
Study Chair: | VASILIOS TASOUDIS, M.D. | Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece |
Study Chair: | KATERINA KYRIAKAKI, M.D. | Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece |
Study Chair: | DEMETRIOS MIKROULIS, M.D. PhD | Department of Cardiothoracic Surgery, University Hospital of Larissa, Greece |
Study Chair: | ATHANASIOS GIANNOUKAS, MD MSc PhD | Department of Vascular Surgery, University Hospital of Larissa, Greece |
Study Chair: | NIKOLAOS TSILIMINGAS, M.D. PhD | Department of Cardiothoracic Surgery, University Hospital of Larissa, Greece |
Responsible Party: | LARISSA UNIVERSITY HOSPITAL/DPT OF ANESTHESIOLOGY ( ATHINA KLEITSAKI ) |
Study ID Numbers: | LUH 1975 AK, POL 1969 TT |
Study First Received: | January 14, 2008 |
Last Updated: | April 8, 2009 |
ClinicalTrials.gov Identifier: | NCT00600704 History of Changes |
Health Authority: | Greece: Ethics Committee; Greece: Ministry of Health and Welfare; Greece: National Organization of Medicines |
Allogenic Blood Use Total Blood Loss Reinfusion of Washed Shed Blood |
Hemorrhage |